GG 705

Pill imprint GG 705 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of stomach ulcer; gerd; gastric ulcer maintenance treatment; indigestion; erosive esophagitis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy.

Ranitidine 150 mg is not subject to the Controlled Substances Act.
See also related documents.

Ranitidine hydrochloride Images

Imprint:
GG 705
Strength:
150 mg
Color:
Pink
Size:
8.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Inactive Ingredients:
D&C Red No. 30
hydroxypropyl cellulose
hypromellose 2910 (3 mPa.s)
magnesium stearate
microcrystalline cellulose
peppermint
sodium starch glycolate type A potato
titanium dioxide
triethyl citrate
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-1883
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0879 UDL Laboratories Inc
63739-0266 McKesson Packaging Services
66267-0188 Nucare Pharmaceuticals Inc (repackager)
57866-6930 Direct Dispensing Inc (repackager)
67544-0049 Prepak Systems Inc (repackager)
21695-0109 Rebel Distributors Corp (repackager)
23490-6249 Palmetto State Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Ranitidine hydrochloride 150 mg GG 705  Front
Ranitidine hydrochloride 150 mg GG 705  Back
Ranitidine hydrochloride 150 mg GG 705
Advertisement
Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web2)